Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer

British Journal of Radiology

Volumn 84, Issue 1007, 2011, Pages 997-1004

  Bharwani, Nishat ^a   Miquel, M E ^a   Sahdev, A ^a   Narayanan, P ^a   Malietzis, G ^a   Reznek, R H ^a   Rockall, A G ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER GRADING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENDOMETRIUM CANCER; ENDOMETRIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; PREDICTIVE VALUE;

ADULT; AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; OBSERVER VARIATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 80054718266     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/14980811     Document Type: Article

References (37)

1. Cancer UK Database. 2010 July. Available from: http://info. cancerresearchuk.org/cancerstats/types/uterus/.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009.
3. SEER Cancer Database. 2010 July. Available from: http://seer.cancer.gov/ statfacts/html/corp.html.
4. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366:491-505. (Pubitemid 41111699)
5. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-18. (Pubitemid 29410973)
6. Koyama T, Tamai K, Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 2007;17: 2009-19. (Pubitemid 47097458)
7. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-8. (Pubitemid 26293285)
8. Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Gynecol Oncol 2009;113:316-23.
9. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4.
10. McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001;82:375-9. (Pubitemid 32730622)
11. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
12. Tozzi R, Malur S, Koehler C, Schneider A. Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 2005;97:4-9. (Pubitemid 40403667)
13. Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol 1996;61:111-23. (Pubitemid 26066071)
14. Dowdy SC, Mariani A. Lymphadenectomy in endometrial cancer: when, not if. Lancet 2010;375:1138-40.
15. Benedetti PP, Basile S, Maneschi F, Alberto LA, Signorelli M, Scambia G et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707-16.
16. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
17. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-72.
18. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-32. (Pubitemid 14105231)
19. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-41. (Pubitemid 17145924)
20. Dubinsky TJ, Parvey HR, Maklad N. The role of transvaginal sonography and endometrial biopsy in the evaluation of peri- and postmenopausal bleeding. AJR Am J Roentgenol 1997;169:145-9. (Pubitemid 27289625)
21. Park BK, Kim B, Park JM, Ryu JA, Kim MS, Bae DS et al. Differentiation of the various lesions causing an abnormality of the endometrial cavity using MR imaging: emphasis on enhancement patterns on dynamic studies and late contrast-enhanced T1-weighted images. Eur Radiol 2006;16:1591-8. (Pubitemid 43871832)
22. Ben Shachar I, Pavelka J, Cohn DE, Copeland LJ, Ramirez N, Manolitsas T et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005;105:487-93. (Pubitemid 40271211)
23. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-35. (Pubitemid 46866868)
24. Fujii S, Matsusue E, Kigawa J, Sato S, Kanasaki Y, Nakanishi J et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008;18:384-9. (Pubitemid 351234060)
25. Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y. Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 2009; 19:745-60.
26. Tamai K, Koyama T, Saga T, Umeoka S, Mikami Y, Fujii S et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007;26:682-7. (Pubitemid 350194592)
27. Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008;190:481-8.
28. Kilickesmez O, Bayramoglu S, Inci E, Cimilli T, Kayhan A. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Acta Radiol 2009;50:340-7.
29. Inada Y, Matsuki M, Nakai G, Tatsugami F, Tanikake M, Narabayashi I et al. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 2009;70:122-7.
30. Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 2009;50: 947-53.
31. Anstee A, Scott F, Culver L, Rustin G, Padwick M, Padhani A. Diffusion-weighted MRI: Correlation with tumour grade in endometrial cancer and normal uterine tissues. Eur Radiol 2007.
32. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17. (Pubitemid 13194678)
33. Mendivil A, Schuler KM, Gehrig PA. Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 2009;16:46-52.
34. Dunton CJ, Balsara G, McFarland M, Hernandez E. Uterine papillary serous carcinoma: a review. Obstet Gynecol Surv 1991;46:97-102.
35. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987;162:297-305. (Pubitemid 17015626)
36. Barwick TD, Rockall AG, Barton DP, Sohaib SA. Imaging of endometrial adenocarcinoma. Clin Radiol 2006;61:545-5.
37. Nakamura K, Kodama J, Okumura Y, Hongo A, Kanazawa S, Hiramatsu Y. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer. Int J Gynecol Cancer 2010;20:110-5.